Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Retacrit 10,000units/1ml inj pre-filled syringes
0901030Q0BBAHAH
|
Retacrit | Epoetin zeta | Nutrition and Blood | 2 |
|
Retacrit 30,000units/0.75ml inj pre-filled syringes
0901030Q0BBAKAK
|
Retacrit | Epoetin zeta | Nutrition and Blood | 1 |
|
Retacrit 1,000units/0.3ml inj pre-filled syringes
0901030Q0BBAAAA
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 2,000units/0.6ml inj pre-filled syringes
0901030Q0BBABAB
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 20,000units/0.5ml inj pre-filled syringes
0901030Q0BBAJAJ
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 3,000units/0.9ml inj pre-filled syringes
0901030Q0BBACAC
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 4,000units/0.4ml inj pre-filled syringes
0901030Q0BBADAD
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 40,000units/1ml inj pre-filled syringes
0901030Q0BBAIAI
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 5,000units/0.5ml inj pre-filled syringes
0901030Q0BBAEAE
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 6,000units/0.6ml inj pre-filled syringes
0901030Q0BBAFAF
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
|
Retacrit 8,000units/0.8ml inj pre-filled syringes
0901030Q0BBAGAG
|
Retacrit | Epoetin zeta | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.